Amalio Telenti
Executive Vice President and Senior Research Fellow @ Vir Biotechnology
yffkk3k3@h27.mp7
Sign up to see email
Known information
- Holds an M.D. and a Ph.D.
- Co-authored a perspective on the future trajectory of COVID-19 published in Nature
- Contributed to research on large language models for science and medicine published in the European Journal of Clinical Investigation
About Vir Biotechnology
Vir Biotechnology is a biotech company headquartered in San Francisco, CA, specializing in the development of treatments for infectious diseases using advanced platforms like monoclonal antibodies and T cell-based viral vectors.